Annual report
6776.TEDINET S100R7QD
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥19.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥15.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥604m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥225m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥752m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥355m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥298m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥976m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥767m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥373m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥246m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥158m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥700m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥589m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥578m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥244m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥27.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥21.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥17.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥16.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥13.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.1bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.3bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.9bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥545m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥496m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥74m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥781m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥35.99 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.47 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.34 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.6 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.5 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥465.86 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥415.13 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥396.84 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥389.44 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥354.29 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 28.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 698 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 691 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 537 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 549 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 559 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥16.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥13.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥13.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥518m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥95m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥677m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥242m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥322m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥885m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥903m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥695m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥248m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥514m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥177m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥232m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥644m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥617m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.8bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥17.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥16.5bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥10.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥10.4bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.0bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥6.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥30.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.43 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.66 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.29 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.19 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥3 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥440.3 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥411.58 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥404.22 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥389.51 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥355.88 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,014,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 389 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 398 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 406 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 404 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 401 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 80
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | −¥7m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥79m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥79m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥2.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | ¥7m |
| Injection Molding Business In Americareportable segment | capex | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥184m |
| Injection Molding Business In Americareportable segment | employees | at 2023-03-31 | 224 pure |
| Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | segment assets | at 2023-03-31 | ¥9.8bn |
| Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥132m |
| Injection Molding Business In Chinareportable segment | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Injection Molding Business In Chinareportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥12m |
| Injection Molding Business In Chinareportable segment | employees | at 2023-03-31 | 27 pure |
| Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥770m |
| Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥729m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥40m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2023-03-31 | ¥663m |
| Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥71m |
| Injection Molding Business In Japanreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Injection Molding Business In Japanreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1.7bn |
| Injection Molding Business In Japanreportable segment | employees | at 2023-03-31 | 420 pure |
| Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥19.3bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥19.3bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥38m |
| Injection Molding Business In Japanreportable segment | segment assets | at 2023-03-31 | ¥19.4bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥423m |
| Real Estate Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥23m |
| Real Estate Businessreportable segment | employees | at 2023-03-31 | 1 pure |
| Real Estate Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥287m |
| Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥287m |
| Real Estate Businessreportable segment | segment assets | at 2023-03-31 | ¥281m |
| Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥233m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥24.0bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥79m |
| —segment total | segment assets | at 2023-03-31 | ¥30.1bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥597m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥36m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥36m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1m |
| Injection Molding Business In Americareportable segment | capex | 2021-04-01 → 2022-03-31 | ¥656m |
| Injection Molding Business In Americareportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥79m |
| Injection Molding Business In Americareportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Injection Molding Business In Americareportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Injection Molding Business In Americareportable segment | segment assets | at 2022-03-31 | ¥3.7bn |
| Injection Molding Business In Americareportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥36m |
| Injection Molding Business In Chinareportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Injection Molding Business In Chinareportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Injection Molding Business In Chinareportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥485m |
| Injection Molding Business In Chinareportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥482m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2022-03-31 | ¥515m |
| Injection Molding Business In Chinareportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥32m |
| Injection Molding Business In Japanreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Injection Molding Business In Japanreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥1.7bn |
| Injection Molding Business In Japanreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥16.3bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥16.2bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥33m |
| Injection Molding Business In Japanreportable segment | segment assets | at 2022-03-31 | ¥19.3bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥70m |
| Real Estate Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥24m |
| Real Estate Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥287m |
| Real Estate Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥287m |
| Real Estate Businessreportable segment | segment assets | at 2022-03-31 | ¥304m |
| Real Estate Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥227m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥19.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥36m |
| —segment total | segment assets | at 2022-03-31 | ¥23.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥227m |
| Injection Molding Business In Japanreportable segment | employees | at 2023-03-31 | 362 pure |
| Real Estate Businessreportable segment | employees | at 2023-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,498
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 79 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 104 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 109 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 124 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.729 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.734 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.450 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.926 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.882 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.960 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.891 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.205 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.109 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.162 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 420 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 136 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 27 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 11 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 224 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01813-000RealEstateBusinessReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 26 | |
| Number of employees | CurrentYearInstant | 698 | |
| Average number of temporary workers | CurrentYearInstant | 147 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 389 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 124 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 40.8 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 12.4 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 3997000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 362 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 124 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01813-000RealEstateBusinessReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 26 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 389 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 124 | |
| Research and development expenses research and development activities | CurrentYearDuration | 3000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 5205000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17014000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17014000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17014000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17014000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 5 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 45 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 17 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 23 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 3980 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 4090 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |